» Authors » Federica Saponaro

Federica Saponaro

Explore the profile of Federica Saponaro including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 37
Citations 499
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Saponaro F, Bertolini A, Baragatti R, Galfo L, Chiellini G, Saba A, et al.
Nutrients . 2024 Dec; 16(23). PMID: 39683426
This review explores the dual role of skeletal muscle as both a mechanical and endocrine organ, highlighting its contributions to overall health and its adaptability to various inputs such as...
2.
Ruggiero M, Giannotta G, Pirani G, Saponaro F, Oliva M, Ferrante C, et al.
Neurol Sci . 2024 Dec; 46(3):1137-1149. PMID: 39630343
Objective: Individuals diagnosed with Spinal Muscular Atrophy (SMA), particularly those presenting with the most severe phenotypes, have long contended with significant swallowing dysfunction. The recent emergence of efficacious advanced therapy...
3.
Campi B, Vitelli V, Saponaro F, Zucchi R, Ferrannini E, Saba A
Clin Chim Acta . 2024 Oct; 565:120023. PMID: 39471893
Recent studies have identified relationships between diabetes mellitus and short-chain fatty acids, including 2-hydroxybutyrate (2-HB) and 2-hydroxyisobutyrate (2-HiB); 2-HB has been associated to the early stages of insulin resistance, while...
4.
Cristiani S, Bertolini A, Carnicelli V, Contu L, Vitelli V, Saba A, et al.
Mol Cell Endocrinol . 2024 Sep; 594:112377. PMID: 39343290
A 3D thyroid model was developed to address the limitations of 2D cultures and study the effects of compounds like 3-MNT on dehalogenase 1 (IYD) and metabolic activity. Morphology was...
5.
Vescini F, Borretta G, Chiodini I, Boniardi M, Carotti M, Castellano E, et al.
Endocr Metab Immune Disord Drug Targets . 2024 Apr; 24(8):991-1006. PMID: 38644730
Aim: This guideline (GL) is aimed at providing a clinical practice reference for the management of sporadic primary hyperparathyroidism (PHPT) in adults. PHPT management in pregnancy was not considered. Methods:...
6.
Dettori C, Ronca F, Di Buono G, Saba A, Di Lupo F, Polini B, et al.
J Pers Med . 2024 Feb; 14(2). PMID: 38392648
Background: Hypoparathyroidism (HypoPT) is characterized by hypocalcemia and undetectable/inappropriately low PTH. Post-surgical HypoPT (PS-HypoPT) is the most common cause. Patients with PS-HypoPT present neuropsychological symptoms, probably due to the PTH...
7.
Vergaro G, Del Franco A, Aimo A, Gentile F, Castiglione V, Saponaro F, et al.
BMC Cardiovasc Disord . 2023 Sep; 23(1):433. PMID: 37658340
Background: Fibroblast growth factor-23 (FGF23) has been associated to left ventricular (LV) hypertrophy and heart failure (HF) severity. We aimed to investigate the clinical correlates and prognostic value of intact...
8.
Polini B, Ricardi C, Bertolini A, Carnicelli V, Rutigliano G, Saponaro F, et al.
Int J Mol Sci . 2023 Jul; 24(14). PMID: 37511328
Microglial dysfunction is one of the hallmarks and leading causes of common neurodegenerative diseases (NDDs), including Alzheimer's disease (AD) and Parkinson's disease (PD). All these pathologies are characterized by aberrant...
9.
Dettori C, Ronca F, Scalese M, Saponaro F
J Pers Med . 2023 May; 13(5). PMID: 37240884
Parathyroid Hormone (PTH) plays a crucial role in the maintenance of calcium homeostasis directly acting on bone and kidneys and indirectly on the intestine. However, a large family of PTH-related...
10.
Battafarano G, Chiellini G, Saponaro F
Front Med (Lausanne) . 2022 May; 9:899416. PMID: 35547231
No abstract available.